Rapid progress of molecular biology makes it possible to
grasp the characteristics of cancer cells on the molecular
level and to develop the "Molecular Target Drug"
which can selectively attack the cancer cell and give little
damage to normal tissues.
We have developed our own tools and technologies to reveal
abnormal human genes. We are able to comprehensively analyze
human genes at a stretch by using our proprietary “Whole
Genome DNA Array” that can identify many new genes with
high amplifications, with its functions unqualified.
Our aim is to make the "Molecular Target Drug"
with high efficiency and little side-effect that can attack
the specific molecules in cancer cells.